09:40 AM EST - Bausch Health Companies Inc. : And its gastroenterology business, Salix Pharmaceuticals, one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, today announced the launch of a series of educational initiatives and resources aimed to reach health care providers and their patients with chronic liver disease. As part of Salix's support for Liver Awareness Month, the company has launched a new, digital destination, "LiverHEalthNow," which offers tools to support the management of Overt Hepatic Encephalopathy (OHE) in chronic liver disease patients. Bausch Health Companies Inc.
shares T.BHC are trading unchanged at $21.01.
